Unknown

Dataset Information

0

Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.


ABSTRACT: Peroxisomal disorders have been associated with malfunction of peroxisomal metabolic pathways, but the pathogenesis of these disorders is largely unknown. X-linked adrenoleukodystrophy (X-ALD) is associated with elevated levels of very-long-chain fatty acids (VLCFA; C(>22:0)) that have been attributed to reduced peroxisomal VLCFA beta-oxidation activity. Previously, our laboratory and others have reported elevated VLCFA levels and reduced peroxisomal VLCFA beta-oxidation in human and mouse X-ALD fibroblasts. In this study, we found normal levels of peroxisomal VLCFA beta-oxidation in tissues from ALD mice with elevated VLCFA levels. Treatment of ALD mice with pharmacological agents resulted in decreased VLCFA levels without a change in VLCFA beta-oxidation activity. These data indicate that ALDP does not determine the rate of VLCFA beta-oxidation and that VLCFA levels are not determined by the rate of VLCFA beta-oxidation. The rate of peroxisomal VLCFA beta-oxidation in human and mouse fibroblasts in vitro is affected by the rate of mitochondrial long-chain fatty acid beta-oxidation. We hypothesize that ALDP facilitates the interaction between peroxisomes and mitochondria, resulting, when ALDP is deficient in X-ALD, in increased VLCFA accumulation despite normal peroxisomal VLCFA beta-oxidation in ALD mouse tissues. In support of this hypothesis, mitochondrial structural abnormalities were observed in adrenal cortical cells of ALD mice.

SUBMITTER: McGuinness MC 

PROVIDER: S-EPMC151532 | biostudies-literature | 2003 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.

McGuinness M C MC   Lu J-F JF   Zhang H-P HP   Dong G-X GX   Heinzer A K AK   Watkins P A PA   Powers J J   Smith K D KD  

Molecular and cellular biology 20030101 2


Peroxisomal disorders have been associated with malfunction of peroxisomal metabolic pathways, but the pathogenesis of these disorders is largely unknown. X-linked adrenoleukodystrophy (X-ALD) is associated with elevated levels of very-long-chain fatty acids (VLCFA; C(>22:0)) that have been attributed to reduced peroxisomal VLCFA beta-oxidation activity. Previously, our laboratory and others have reported elevated VLCFA levels and reduced peroxisomal VLCFA beta-oxidation in human and mouse X-ALD  ...[more]

Similar Datasets

| S-EPMC5675651 | biostudies-literature
| S-EPMC3534082 | biostudies-literature
| S-EPMC7090298 | biostudies-literature
| S-EPMC4660798 | biostudies-literature
| S-EPMC3755581 | biostudies-literature
| S-EPMC10276915 | biostudies-literature
| S-EPMC9665428 | biostudies-literature
| S-EPMC3048694 | biostudies-literature
| S-EPMC419992 | biostudies-literature
| S-EPMC6323035 | biostudies-literature